Symbols / BDMD Stock $1.68 -4.00% Baird Medical Investment Holdings Limited
BDMD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Ratings
Current target
$1.68
Low
—
High
—
Mean
—
- China slowdown hit Baird Medical as it builds U.S. sales push - Stock Titan Wed, 29 Apr 2026 12
- BDMD Should I Buy - Intellectia AI Fri, 24 Apr 2026 07
- BDMD Financials: Income Statement, Balance Sheet & Cash Flow | Baird Medical - Stock Titan Fri, 24 Apr 2026 22
- Declining Stock and Solid Fundamentals: Is The Market Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD)? - Yahoo Finance Wed, 01 Oct 2025 07
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st ue, 07 Oct 2025 07
- BDMD Stock Rises on Strategic Expansion Moves - StocksToTrade Fri, 20 Feb 2026 08
- BDMD Stock Analysis: Key Insights and Market Trends - timothysykes.com Fri, 20 Feb 2026 08
- BDMD Stock Surges Amid Strategic Moves and Market Dynamics - StocksToTrade Fri, 20 Feb 2026 08
- AI maps surgeons' moves: Baird Medical readies software for US, EU, China - Stock Titan Wed, 04 Mar 2026 08
- BDMD.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI Sat, 28 Feb 2026 11
- Could The Market Be Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Given Its Attractive Financial Prospects? - simplywall.st Sat, 27 Sep 2025 07
- Argentina clears minimally invasive ablation tech from Baird Medical - Stock Titan hu, 12 Mar 2026 07
- In Miami, Baird Medical shows doctors minimally invasive endocrine tools - Stock Titan Mon, 02 Mar 2026 08
- Less-invasive thyroid treatment gains ground with Baird Medical in U.S. - Stock Titan Wed, 25 Feb 2026 08
- Needle-based thyroid therapy avoiding surgery scars heads to 3 US conferences - Stock Titan hu, 19 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
22.54
-39.15%
|
37.04
+17.74%
|
31.46
-10.35%
|
35.09
|
| Operating Revenue |
|
22.54
-39.15%
|
37.04
+17.74%
|
31.46
-10.35%
|
35.09
|
| Cost Of Revenue |
|
3.65
-16.66%
|
4.38
+3.69%
|
4.23
-40.07%
|
7.05
|
| Reconciled Cost Of Revenue |
|
3.65
-16.66%
|
4.38
+3.69%
|
4.23
-40.07%
|
7.05
|
| Gross Profit |
|
18.88
-42.17%
|
32.65
+19.92%
|
27.23
-2.88%
|
28.04
|
| Operating Expense |
|
44.42
+156.20%
|
17.34
+18.95%
|
14.58
+11.87%
|
13.03
|
| Research And Development |
|
20.13
+226.04%
|
6.17
+44.43%
|
4.27
+10.77%
|
3.86
|
| Selling General And Administration |
|
24.38
+118.41%
|
11.16
+0.64%
|
11.09
+9.35%
|
10.15
|
| Selling And Marketing Expense |
|
10.26
+152.75%
|
4.06
+59.45%
|
2.55
-28.96%
|
3.59
|
| General And Administrative Expense |
|
14.12
+98.77%
|
7.10
-16.89%
|
8.55
+30.28%
|
6.56
|
| Other Gand A |
|
14.12
+98.77%
|
7.10
-16.89%
|
8.55
+30.28%
|
6.56
|
| Other Operating Expenses |
|
-0.09
-35010.53%
|
-0.00
+99.97%
|
-0.79
+42.42%
|
-1.38
|
| Total Expenses |
|
48.07
+121.32%
|
21.72
+15.52%
|
18.80
-6.37%
|
20.08
|
| Operating Income |
|
-25.54
-266.74%
|
15.32
+21.03%
|
12.65
-15.68%
|
15.01
|
| Total Operating Income As Reported |
|
-25.63
-267.36%
|
15.32
+29.11%
|
11.86
-12.98%
|
13.63
|
| EBITDA |
|
-24.53
-255.25%
|
15.80
+15.70%
|
13.66
-16.16%
|
16.29
|
| Normalized EBITDA |
|
-24.53
-255.25%
|
15.80
+15.70%
|
13.66
-16.16%
|
16.29
|
| Reconciled Depreciation |
|
1.10
-3.08%
|
1.14
+12.30%
|
1.01
-31.00%
|
1.47
|
| EBIT |
|
-25.64
-274.84%
|
14.66
+15.98%
|
12.64
-14.69%
|
14.82
|
| Net Income |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Pretax Income |
|
-26.37
-287.23%
|
14.09
+13.98%
|
12.36
-14.89%
|
14.52
|
| Net Non Operating Interest Income Expense |
|
-0.74
-27.94%
|
-0.58
-102.75%
|
-0.28
+2.22%
|
-0.29
|
| Interest Expense Non Operating |
|
0.74
+27.94%
|
0.58
+102.75%
|
0.28
-5.01%
|
0.30
|
| Net Interest Income |
|
-0.74
-27.94%
|
-0.58
-102.75%
|
-0.28
+2.22%
|
-0.29
|
| Interest Expense |
|
0.74
+27.94%
|
0.58
+102.75%
|
0.28
-5.01%
|
0.30
|
| Interest Income Non Operating |
|
—
|
0.00
-74.84%
|
0.00
-81.74%
|
0.01
|
| Interest Income |
|
—
|
0.00
-74.84%
|
0.00
-81.74%
|
0.01
|
| Other Income Expense |
|
-0.10
+84.62%
|
-0.65
-6281.91%
|
-0.01
+94.75%
|
-0.19
|
| Other Non Operating Income Expenses |
|
-0.10
+84.62%
|
-0.65
-6281.91%
|
-0.01
+94.75%
|
-0.19
|
| Tax Provision |
|
1.17
-21.69%
|
1.49
-12.45%
|
1.70
-2.63%
|
1.75
|
| Tax Rate For Calcs |
|
0.00
+136.49%
|
0.00
-23.19%
|
0.00
+14.41%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-27.54
-318.61%
|
12.60
+18.20%
|
10.66
-16.57%
|
12.77
|
| Net Income From Continuing Operation Net Minority Interest |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Net Income From Continuing And Discontinued Operation |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Net Income Continuous Operations |
|
-27.54
-318.61%
|
12.60
+18.20%
|
10.66
-16.57%
|
12.77
|
| Minority Interests |
|
0.26
+281.80%
|
-0.14
-28.99%
|
-0.11
+45.59%
|
-0.21
|
| Normalized Income |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Net Income Common Stockholders |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Diluted EPS |
|
—
|
0.57
+38.12%
|
0.41
-16.09%
|
0.49
|
| Basic EPS |
|
—
|
0.57
+38.12%
|
0.41
-16.09%
|
0.49
|
| Basic Average Shares |
|
—
|
21.83
-14.59%
|
25.56
+0.00%
|
25.56
|
| Diluted Average Shares |
|
—
|
21.83
-14.59%
|
25.56
+0.00%
|
25.56
|
| Diluted NI Availto Com Stockholders |
|
-27.28
-319.04%
|
12.45
+18.09%
|
10.55
-16.09%
|
12.57
|
| Average Dilution Earnings |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Provision For Doubtful Accounts |
|
—
|
1.20
-45.45%
|
2.20
+450.00%
|
0.40
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Assets |
|
69.70
-10.60%
|
77.96
|
| Current Assets |
|
54.97
-10.50%
|
61.42
|
| Cash Cash Equivalents And Short Term Investments |
|
0.18
-94.00%
|
2.97
|
| Cash And Cash Equivalents |
|
0.18
-94.00%
|
2.97
|
| Cash Financial |
|
0.18
-94.00%
|
2.97
|
| Receivables |
|
42.53
-8.69%
|
46.58
|
| Accounts Receivable |
|
42.53
-8.69%
|
46.58
|
| Gross Accounts Receivable |
|
47.29
-6.49%
|
50.57
|
| Allowance For Doubtful Accounts Receivable |
|
-4.76
-19.12%
|
-3.99
|
| Taxes Receivable |
|
—
|
—
|
| Inventory |
|
1.09
-16.26%
|
1.30
|
| Raw Materials |
|
0.37
+7.40%
|
0.35
|
| Work In Process |
|
0.20
-13.16%
|
0.23
|
| Finished Goods |
|
0.51
-28.76%
|
0.72
|
| Prepaid Assets |
|
10.55
+2.64%
|
10.27
|
| Restricted Cash |
|
0.39
|
0.00
|
| Other Current Assets |
|
0.24
-18.67%
|
0.30
|
| Total Non Current Assets |
|
14.73
-10.97%
|
16.55
|
| Net PPE |
|
6.55
-14.05%
|
7.62
|
| Gross PPE |
|
12.47
+2.11%
|
12.21
|
| Accumulated Depreciation |
|
-5.92
-28.90%
|
-4.59
|
| Properties |
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
7.43
+4.99%
|
7.08
|
| Other Properties |
|
0.52
-35.36%
|
0.81
|
| Leases |
|
4.52
+4.38%
|
4.33
|
| Goodwill And Other Intangible Assets |
|
0.07
-7.23%
|
0.07
|
| Goodwill |
|
0.06
+4.38%
|
0.06
|
| Other Intangible Assets |
|
0.01
-47.81%
|
0.02
|
| Non Current Deferred Assets |
|
0.76
+6.69%
|
0.71
|
| Non Current Deferred Taxes Assets |
|
0.76
+6.69%
|
0.71
|
| Non Current Prepaid Assets |
|
7.11
-11.32%
|
8.02
|
| Other Non Current Assets |
|
0.24
+98.51%
|
0.12
|
| Total Liabilities Net Minority Interest |
|
38.48
+0.72%
|
38.20
|
| Current Liabilities |
|
32.36
-6.53%
|
34.62
|
| Payables And Accrued Expenses |
|
18.38
+11.46%
|
16.49
|
| Payables |
|
15.63
+11.91%
|
13.97
|
| Accounts Payable |
|
1.81
+44.10%
|
1.25
|
| Other Payable |
|
5.84
-4.86%
|
6.14
|
| Current Accrued Expenses |
|
2.74
+8.98%
|
2.52
|
| Total Tax Payable |
|
3.10
+7.83%
|
2.87
|
| Income Tax Payable |
|
0.46
+484.30%
|
0.08
|
| Current Debt And Capital Lease Obligation |
|
13.18
-23.78%
|
17.30
|
| Current Debt |
|
13.07
-23.28%
|
17.03
|
| Other Current Borrowings |
|
2.64
+203.89%
|
0.87
|
| Current Capital Lease Obligation |
|
0.12
-56.48%
|
0.26
|
| Current Deferred Liabilities |
|
0.80
-4.20%
|
0.84
|
| Current Deferred Revenue |
|
0.79
+0.17%
|
0.79
|
| Total Non Current Liabilities Net Minority Interest |
|
6.11
+70.82%
|
3.58
|
| Long Term Debt And Capital Lease Obligation |
|
6.11
+70.82%
|
3.58
|
| Long Term Debt |
|
6.09
+76.80%
|
3.44
|
| Long Term Capital Lease Obligation |
|
0.03
-79.78%
|
0.14
|
| Stockholders Equity |
|
31.37
-20.91%
|
39.66
|
| Common Stock Equity |
|
31.37
-20.91%
|
39.66
|
| Capital Stock |
|
0.00
+20.08%
|
0.00
|
| Common Stock |
|
0.00
+20.31%
|
0.00
|
| Preferred Stock |
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
40.98
+14.70%
|
35.73
|
| Ordinary Shares Number |
|
30.75
+20.34%
|
25.56
|
| Treasury Shares Number |
|
10.23
+0.53%
|
10.17
|
| Additional Paid In Capital |
|
28.66
+150.47%
|
11.44
|
| Retained Earnings |
|
-0.52
-101.93%
|
26.76
|
| Gains Losses Not Affecting Retained Earnings |
|
3.22
+122.15%
|
1.45
|
| Minority Interest |
|
-0.14
-242.18%
|
0.10
|
| Other Equity Adjustments |
|
3.22
+122.15%
|
1.45
|
| Total Equity Gross Minority Interest |
|
31.22
-21.47%
|
39.76
|
| Total Capitalization |
|
37.45
-13.10%
|
43.10
|
| Working Capital |
|
22.61
-15.62%
|
26.79
|
| Invested Capital |
|
50.52
-15.99%
|
60.14
|
| Total Debt |
|
19.30
-7.57%
|
20.88
|
| Net Debt |
|
18.98
+8.40%
|
17.51
|
| Capital Lease Obligations |
|
0.14
-64.42%
|
0.40
|
| Net Tangible Assets |
|
31.30
-20.93%
|
39.58
|
| Tangible Book Value |
|
31.30
-20.93%
|
39.58
|
| Current Deferred Taxes Liabilities |
|
0.01
-80.64%
|
0.05
|
| Duefrom Related Parties Current |
|
0.00
+4.37%
|
0.00
|
| Dueto Related Parties Current |
|
4.89
+31.98%
|
3.70
|
| Line Of Credit |
|
10.43
-35.47%
|
16.17
|
| Preferred Stock Equity |
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-1.34
+78.71%
|
-6.31
-518.95%
|
-1.02
-309.88%
|
0.49
|
| Cash Flow From Continuing Operating Activities |
|
-1.66
+75.21%
|
-6.68
-385.11%
|
-1.38
-383.41%
|
0.49
|
| Net Income From Continuing Operations |
|
-27.54
-318.61%
|
12.60
+18.20%
|
10.66
-16.57%
|
12.77
|
| Depreciation Amortization Depletion |
|
1.10
-3.08%
|
1.14
+12.30%
|
1.01
-31.00%
|
1.47
|
| Depreciation |
|
1.41
+282.26%
|
0.37
+3.06%
|
0.36
-75.69%
|
1.47
|
| Amortization Cash Flow |
|
0.01
|
—
|
—
|
—
|
| Depreciation And Amortization |
|
1.10
-3.08%
|
1.14
+12.30%
|
1.01
-31.00%
|
1.47
|
| Amortization Of Intangibles |
|
0.01
|
—
|
—
|
—
|
| Other Non Cash Items |
|
0.31
-15.27%
|
0.37
+3.06%
|
0.36
|
—
|
| Stock Based Compensation |
|
17.47
|
0.00
|
0.00
|
—
|
| Provisionand Write Offof Assets |
|
0.57
-54.06%
|
1.25
-46.72%
|
2.34
+432.83%
|
0.44
|
| Deferred Tax |
|
-0.05
-263.24%
|
0.03
+106.05%
|
-0.54
-278.17%
|
-0.14
|
| Deferred Income Tax |
|
-0.05
-263.24%
|
0.03
+106.05%
|
-0.54
-278.17%
|
-0.14
|
| Operating Gains Losses |
|
—
|
—
|
—
|
-0.01
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Change In Working Capital |
|
6.79
+131.30%
|
-21.70
-46.14%
|
-14.85
-5.68%
|
-14.05
|
| Change In Receivables |
|
5.35
+130.05%
|
-17.80
-83.99%
|
-9.67
+31.40%
|
-14.10
|
| Changes In Account Receivables |
|
5.35
+130.05%
|
-17.80
-83.99%
|
-9.67
+34.80%
|
-14.84
|
| Change In Inventory |
|
0.26
+238.78%
|
-0.19
-265.00%
|
0.11
-92.75%
|
1.57
|
| Change In Prepaid Assets |
|
1.35
+127.99%
|
-4.84
+11.11%
|
-5.44
-57.70%
|
-3.45
|
| Change In Payables And Accrued Expense |
|
0.13
-90.15%
|
1.31
+125.51%
|
0.58
-75.53%
|
2.38
|
| Change In Accrued Expense |
|
-0.45
+71.23%
|
-1.57
-229.13%
|
1.21
-9.63%
|
1.34
|
| Change In Payable |
|
0.58
-79.86%
|
2.88
+556.79%
|
-0.63
-160.73%
|
1.04
|
| Change In Account Payable |
|
0.48
-33.51%
|
0.73
+113.10%
|
0.34
+438.36%
|
-0.10
|
| Change In Other Working Capital |
|
-0.03
-110.47%
|
0.31
+279.17%
|
-0.17
-480.87%
|
0.05
|
| Change In Other Current Assets |
|
—
|
0.00
+100.00%
|
-0.01
+98.97%
|
-0.88
|
| Change In Other Current Liabilities |
|
-0.27
+46.05%
|
-0.50
-96.15%
|
-0.25
-165.11%
|
0.39
|
| Investing Cash Flow |
|
-0.04
+98.28%
|
-2.47
+7.00%
|
-2.65
+55.20%
|
-5.92
|
| Cash Flow From Continuing Investing Activities |
|
-0.04
+98.28%
|
-2.47
+7.00%
|
-2.65
+55.20%
|
-5.92
|
| Net PPE Purchase And Sale |
|
-0.04
+98.52%
|
-2.85
-8.16%
|
-2.64
+55.10%
|
-5.88
|
| Purchase Of PPE |
|
-0.04
+98.52%
|
-2.85
-8.16%
|
-2.64
+55.35%
|
-5.91
|
| Sale Of PPE |
|
—
|
0.00
|
0.00
-100.00%
|
0.03
|
| Capital Expenditure |
|
-0.04
+98.52%
|
-2.85
-8.16%
|
-2.64
+55.69%
|
-5.95
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-0.04
|
| Purchase Of Intangibles |
|
—
|
0.00
|
0.00
+100.00%
|
-0.04
|
| Net Other Investing Changes |
|
—
|
0.39
+2836.27%
|
-0.01
|
—
|
| Financing Cash Flow |
|
-1.39
-113.49%
|
10.33
+197.36%
|
3.48
-21.23%
|
4.41
|
| Cash Flow From Continuing Financing Activities |
|
-1.39
-113.49%
|
10.33
+197.36%
|
3.48
-21.23%
|
4.41
|
| Net Issuance Payments Of Debt |
|
-2.16
-120.92%
|
10.31
+130.58%
|
4.47
+0.32%
|
4.46
|
| Issuance Of Debt |
|
17.94
-18.85%
|
22.10
+81.92%
|
12.15
+34.03%
|
9.07
|
| Repayment Of Debt |
|
-20.09
-70.42%
|
-11.79
-53.57%
|
-7.68
-66.65%
|
-4.61
|
| Long Term Debt Issuance |
|
6.39
+129.90%
|
2.78
+9.07%
|
2.55
|
0.00
|
| Long Term Debt Payments |
|
-2.28
-182.88%
|
-0.81
-315.77%
|
-0.19
|
0.00
|
| Net Long Term Debt Issuance |
|
4.11
+108.24%
|
1.97
-16.20%
|
2.35
|
0.00
|
| Short Term Debt Issuance |
|
11.55
-40.25%
|
19.32
+101.26%
|
9.60
+5.92%
|
9.07
|
| Short Term Debt Payments |
|
-17.81
-62.16%
|
-10.98
-46.77%
|
-7.48
-62.44%
|
-4.61
|
| Net Short Term Debt Issuance |
|
-6.27
-175.14%
|
8.34
+293.77%
|
2.12
-52.49%
|
4.46
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
2.90
|
0.00
|
0.00
|
| Common Stock Dividend Paid |
|
—
|
—
|
—
|
0.00
|
| Cash Dividends Paid |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
0.76
+126.52%
|
-2.88
-188.63%
|
-1.00
-2049.93%
|
-0.05
|
| Changes In Cash |
|
-2.78
-278.91%
|
1.55
+887.49%
|
-0.20
+80.72%
|
-1.02
|
| Effect Of Exchange Rate Changes |
|
0.38
+498.62%
|
-0.09
-2933.24%
|
-0.00
+98.96%
|
-0.30
|
| Beginning Cash Position |
|
2.97
+96.64%
|
1.51
-11.72%
|
1.71
-43.57%
|
3.03
|
| End Cash Position |
|
0.57
-80.95%
|
2.97
+96.64%
|
1.51
-11.72%
|
1.71
|
| Free Cash Flow |
|
-1.39
+84.88%
|
-9.17
-150.56%
|
-3.66
+33.10%
|
-5.47
|
| Interest Paid Supplemental Data |
|
0.74
+27.90%
|
0.58
+101.78%
|
0.29
+17.22%
|
0.24
|
| Income Tax Paid Supplemental Data |
|
0.84
-54.48%
|
1.84
-30.52%
|
2.64
+83.72%
|
1.44
|
| Change In Income Tax Payable |
|
0.10
-95.52%
|
2.15
+321.53%
|
-0.97
-185.31%
|
1.14
|
| Change In Tax Payable |
|
0.10
-95.52%
|
2.15
+321.53%
|
-0.97
-185.31%
|
1.14
|
| Common Stock Issuance |
|
0.00
-100.00%
|
2.90
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
2.90
|
0.00
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|